In January 2021 FDA approval was received for Testosterone Topical Solution, 30mg /1.5mL, a generic to Padagis Testosterone Topical Solution, 30mg/1.5mL. An exclusive sales, marketing and distribution agreement was signed with Dash Pharmaceuticals.
DASH is a privately held, specialty pharmaceutical company. The company markets, sells , and distributes generic pharmaceutical products, packaged in the “DASH” label. The DASH team continually evaluates and identifies generic product opportunities, across multiple dosage forms and therapeutic categories for sale in retail, institutional and other US pharmaceutical markets. Through partnerships with quality pharmaceutical developers and manufacturers around the world, the company co-develops and licenses products for its distribution.
For further information on Dash Pharmaceuticals LLC, visit www.dashpharm.com